Improved survival of multiple myeloma patients treated with autologous transplantation in the modern era of new medicine

New drugs for multiple myeloma (MM) have dramatically improved patients’ overall survival (OS). Autologous stem cell transplantation (ASCT) remains the mainstay for transplant‐eligible MM patients. To investigate whether the post‐ASCT prognosis of MM patients has been improved by new drugs, we under...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimazu, Yutaka, Mizuno, Shohei, Fuchida, Shin‐ichi, Suzuki, Kazuhito, Tsukada, Nobuhiro, Hanagaishi, Akira, Itagaki, Mitsuhiro, Kataoka, Keisuke, Kako, Shinichi, Sakaida, Emiko, Yoshioka, Satoshi, Iida, Shinsuke, Doki, Noriko, Oyake, Tatsuo, Ichinohe, Tatsuo, Kanda, Yoshinobu, Astuta, Yoshiko, Takamatsu, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645729/
https://www.ncbi.nlm.nih.gov/pubmed/34644446
http://dx.doi.org/10.1111/cas.15163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645729/
https://www.ncbi.nlm.nih.gov/pubmed/34644446
http://dx.doi.org/10.1111/cas.15163

Ejemplares similares